The cancer-testis antigen BORIS phenocopies the tumor suppressor CTCF in normal and neoplastic cells

作者: Jessamy C. Tiffen , Charles G. Bailey , Amy D. Marshall , Cynthia Metierre , Yue Feng

DOI: 10.1002/IJC.28184

关键词:

摘要: BORIS and CTCF are paralogous, multivalent 11-zinc finger transcription factors that play important roles in organizing higher-order chromatin architecture. is a cancer-testis antigen with poorly defined function cancer, although it has been hypothesized to exhibit oncogenic properties. CTCF, however, postulated as candidate tumor suppressor. We collated the genetic lesions from multiple cancers identified using high-throughput genomics. In BORIS, nonsense missense mutations evenly distributed. recurrent mostly clustered conserved zinc domain at residues critical for contacting DNA ion co-ordination. Three common both proteins. used an inducible lentivector express wildtype or primary cells cancer cell lines order define their functional differences. Both caused significant decrease proliferation clonogenic capacity, without alteration of specific cycle phases. conferred protective effects some during UV damage-induced apoptosis. Using bioluminescent MCF-7 orthotopic breast model vivo, we demonstrated suppressed growth. These findings provide further evidence behaves suppressor, show similar growth inhibitory effect vitro vivo. Hence, acquired may disrupt these functions, thereby contributing development.

参考文章(51)
S.A. Forbes, G. Bhamra, S. Bamford, E. Dawson, C. Kok, J. Clements, A. Menzies, J.W. Teague, P.A. Futreal, M.R. Stratton, The Catalogue of Somatic Mutations in Cancer (COSMIC). Current protocols in human genetics. ,vol. 57, ,(2008) , 10.1002/0471142905.HG1011S57
T LI, L LU, Functional role of CCCTC binding factor (CTCF) in stress-induced apoptosis Experimental Cell Research. ,vol. 313, pp. 3057- 3065 ,(2007) , 10.1016/J.YEXCR.2007.05.018
Jeff Holst, Kate M Vignali, Amanda R Burton, Dario A A Vignali, Rapid analysis of T-cell selection in vivo using T cell-receptor retrogenic mice. Nature Methods. ,vol. 3, pp. 191- 197 ,(2006) , 10.1038/NMETH858
Manuel Rosa-Garrido, Laura Ceballos, Pilar Alonso-Lecue, Cristina Abraira, M. Dolores Delgado, Alberto Gandarillas, A Cell Cycle Role for the Epigenetic Factor CTCF-L/BORIS PLoS ONE. ,vol. 7, pp. e39371- ,(2012) , 10.1371/JOURNAL.PONE.0039371
Ayman El-Kady, Elena Klenova, Regulation of the transcription factor, CTCF, by phosphorylation with protein kinase CK2. FEBS Letters. ,vol. 579, pp. 1424- 1434 ,(2005) , 10.1016/J.FEBSLET.2005.01.044
Charles G Mullighan, Jinghui Zhang, Lawryn H Kasper, Stephanie Lerach, Debbie Payne-Turner, Letha A Phillips, Sue L Heatley, Linda Holmfeldt, J Racquel Collins-Underwood, Jing Ma, Kenneth H Buetow, Ching-Hon Pui, Sharyn D Baker, Paul K Brindle, James R Downing, None, CREBBP mutations in relapsed acute lymphoblastic leukaemia Nature. ,vol. 471, pp. 235- 239 ,(2011) , 10.1038/NATURE09727
Verónica Torrano, Igor Chernukhin, France Docquier, Vivien D'Arcy, Javier León, Elena Klenova, M. Dolores Delgado, CTCF regulates growth and erythroid differentiation of human myeloid leukemia cells. Journal of Biological Chemistry. ,vol. 280, pp. 28152- 28161 ,(2005) , 10.1074/JBC.M501481200
Tania A. Jones, Babatunji W. Ogunkolade, Jaroslaw Szary, Johan Aarum, Muhammad A. Mumin, Shyam Patel, Christopher A. Pieri, Denise Sheer, Widespread Expression of BORIS/CTCFL in Normal and Cancer Cells PLoS ONE. ,vol. 6, pp. e22399- ,(2011) , 10.1371/JOURNAL.PONE.0022399